Tatsuya J Arai1, Donghan M Yang1, James W Campbell1, Tsuicheng Chiu2, Xinyi Cheng2, Strahinja Stojadinovic2, Peter Peschke3, Ralph P Mason4. 1. Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas. 2. Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas. 3. German Cancer Center, Heidelberg, Germany. 4. Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas. Electronic address: Ralph.Mason@UTSouthwestern.edu.
Abstract
PURPOSE: To develop a noninvasive prognostic imaging biomarker related to hypoxia to predict SABR tumor control. METHODS AND MATERIALS: A total of 145 subcutaneous syngeneic Dunning prostate R3327-AT1 rat tumors were focally irradiated once using cone beam computed tomography guidance on a small animal irradiator at 225 kV. Various doses in the range of 0 to 100 Gy were administered, while rats breathed air or oxygen, and tumor control was assessed up to 200 days. Oxygen-sensitive magnetic resonance imaging (MRI) (T1-weighted, ΔR1, ΔR2*) was applied to 79 of these tumors at 4.7 T to assess response to an oxygen gas breathing challenge on the day before irradiation as a probe of tumor hypoxia. RESULTS: Increasing radiation dose in the range of 0 to 90 Gy enhanced tumor control of air-breathing rats with a TCD50 estimated at 59.6 ± 1.5 Gy. Control was significantly improved at some doses when rats breathed oxygen during irradiation (eg, 40 Gy; P < .05), and overall there was a modest left shift in the control curve: TCD50(oxygen) = 53.1 ± 3.1 Gy (P < .05 vs air). Oxygen-sensitive MRI showed variable response to oxygen gas breathing challenge; the magnitude of T1-weighted signal response (%ΔSI) allowed stratification of tumors in terms of local control at 40 Gy. Tumors showing %ΔSI >0.922 with O2-gas breathing challenge showed significantly better control at 40 Gy during irradiation while breathing oxygen (75% vs 0%, P < .01). In addition, increased radiation dose (50 Gy) substantially overcame resistance, with 50% control for poorly oxygenated tumors. Stratification of dose-response curves based on %ΔSI >0.922 revealed different survival curves, with TCD50 = 36.2 ± 3.2 Gy for tumors responsive to oxygen gas breathing challenge; this was significantly less than the 54.7 ± 2.4 Gy for unresponsive tumors (P < .005), irrespective of the gas inhaled during tumor irradiation. CONCLUSIONS: Oxygen-sensitive MRI allowed stratification of tumors in terms of local control at 40 Gy, indicating its use as a potential predictive imaging biomarker. Increasing dose to 50 Gy overcame radiation resistance attributable to hypoxia in 50% of tumors.
PURPOSE: To develop a noninvasive prognostic imaging biomarker related to hypoxia to predict SABR tumor control. METHODS AND MATERIALS: A total of 145 subcutaneous syngeneic Dunning prostate R3327-AT1 rat tumors were focally irradiated once using cone beam computed tomography guidance on a small animal irradiator at 225 kV. Various doses in the range of 0 to 100 Gy were administered, while rats breathed air or oxygen, and tumor control was assessed up to 200 days. Oxygen-sensitive magnetic resonance imaging (MRI) (T1-weighted, ΔR1, ΔR2*) was applied to 79 of these tumors at 4.7 T to assess response to an oxygen gas breathing challenge on the day before irradiation as a probe of tumor hypoxia. RESULTS: Increasing radiation dose in the range of 0 to 90 Gy enhanced tumor control of air-breathing rats with a TCD50 estimated at 59.6 ± 1.5 Gy. Control was significantly improved at some doses when rats breathed oxygen during irradiation (eg, 40 Gy; P < .05), and overall there was a modest left shift in the control curve: TCD50(oxygen) = 53.1 ± 3.1 Gy (P < .05 vs air). Oxygen-sensitive MRI showed variable response to oxygen gas breathing challenge; the magnitude of T1-weighted signal response (%ΔSI) allowed stratification of tumors in terms of local control at 40 Gy. Tumors showing %ΔSI >0.922 with O2-gas breathing challenge showed significantly better control at 40 Gy during irradiation while breathing oxygen (75% vs 0%, P < .01). In addition, increased radiation dose (50 Gy) substantially overcame resistance, with 50% control for poorly oxygenated tumors. Stratification of dose-response curves based on %ΔSI >0.922 revealed different survival curves, with TCD50 = 36.2 ± 3.2 Gy for tumors responsive to oxygen gas breathing challenge; this was significantly less than the 54.7 ± 2.4 Gy for unresponsive tumors (P < .005), irrespective of the gas inhaled during tumor irradiation. CONCLUSIONS: Oxygen-sensitive MRI allowed stratification of tumors in terms of local control at 40 Gy, indicating its use as a potential predictive imaging biomarker. Increasing dose to 50 Gy overcame radiation resistance attributable to hypoxia in 50% of tumors.
Authors: Bernard Gallez; Marie-Aline Neveu; Pierre Danhier; Bénédicte F Jordan Journal: Biochim Biophys Acta Bioenerg Date: 2017-01-12 Impact factor: 3.991
Authors: Ken-ichiro Matsumoto; Marcelino Bernardo; Sankaran Subramanian; Peter Choyke; James B Mitchell; Murali C Krishna; Martin J Lizak Journal: Magn Reson Med Date: 2006-08 Impact factor: 4.668
Authors: Scott C Beeman; Ying-Bo Shui; Carlos J Perez-Torres; John A Engelbach; Joseph J H Ackerman; Joel R Garbow Journal: Magn Reson Med Date: 2015-07-14 Impact factor: 4.668
Authors: Aruna Turaka; Mark K Buyyounouski; Alexandra L Hanlon; Eric M Horwitz; Richard E Greenberg; Benjamin Movsas Journal: Int J Radiat Oncol Biol Phys Date: 2011-10-08 Impact factor: 7.038
Authors: Christin Glowa; Christian P Karger; Stephan Brons; Dawen Zhao; Ralph P Mason; Peter E Huber; Jürgen Debus; Peter Peschke Journal: Cancer Lett Date: 2016-05-17 Impact factor: 8.679
Authors: Olivia J Kelada; Roy H Decker; Sameer K Nath; Kimberly L Johung; Ming-Qiang Zheng; Yiyun Huang; Jean-Dominique Gallezot; Chi Liu; Richard E Carson; Uwe Oelfke; David J Carlson Journal: Int J Radiat Oncol Biol Phys Date: 2018-06-01 Impact factor: 7.038
Authors: Nancy Lee; Heiko Schoder; Brad Beattie; Ryan Lanning; Nadeem Riaz; Sean McBride; Nora Katabi; Duan Li; Brett Yarusi; Susie Chan; Lindsey Mitrani; Zhigang Zhang; David G Pfister; Eric Sherman; Shrujal Baxi; Jay Boyle; Luc G T Morris; Ian Ganly; Richard Wong; John Humm Journal: Int J Radiat Oncol Biol Phys Date: 2016-05-07 Impact factor: 7.038
Authors: Rosie J Goodburn; Marielle E P Philippens; Thierry L Lefebvre; Aly Khalifa; Tom Bruijnen; Joshua N Freedman; David E J Waddington; Eyesha Younus; Eric Aliotta; Gabriele Meliadò; Teo Stanescu; Wajiha Bano; Ali Fatemi-Ardekani; Andreas Wetscherek; Uwe Oelfke; Nico van den Berg; Ralph P Mason; Petra J van Houdt; James M Balter; Oliver J Gurney-Champion Journal: Magn Reson Med Date: 2022-09-21 Impact factor: 3.737
Authors: Thierry L Lefebvre; Emma Brown; Lina Hacker; Thomas Else; Mariam-Eleni Oraiopoulou; Michal R Tomaszewski; Rajesh Jena; Sarah E Bohndiek Journal: Front Oncol Date: 2022-03-03 Impact factor: 5.738